Đang chuẩn bị liên kết để tải về tài liệu:
Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Mitiglinide is a widely used agent for diabetic treatment. We established a pharmacokineticpharmacodynamic (PK-PD) model to illustrate the relationship between mitiglinide plasma concentration and its glucose lowering effects in healthy volunteers. | Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers

TÀI LIỆU LIÊN QUAN

Effects of semi-solidification of enteral nutrients on the pharmacokinetic behavior of orally administered carbamazepine in rats

Studies on the pharmacokinetic interaction between meloxicam and quercetin, a cyp2c9 and cyp3a4 inhibiting flavonoid, in Rabbits

Pharmacokinetic activity of quercetin in rats following single dose intramuscular administration

Ebook Pharmacology for anaesthesia and intensive care (4/E): Part 1

Does the systemic plasma profile inform the liver profile? Analysis using a physiologically based pharmacokinetic model and individual compounds

Improved bioavailability of timolol maleate via transdermal transfersomal gel: Statistical optimization, characterization, and pharmacokinetic assessment

Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy

CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe

Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men

Novel LC–MS/MS method for analysis of metformin and canagliflozin in human plasma: Application to a pharmacokinetic study